Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

COVID19 (SARS-CoV2) vaccination/vaccine

5

XII.q Pericarditis (see also under XIIc)

1
Last update : 23/07/2021
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report.
European heart journal. Case reports 2022 Sep;6;ytac357 2022 Sep
Acute Pericarditis Post mRNA-1273 COVID Vaccine Booster.
Cureus 2022 Feb;14;e22148 2022 Feb
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Annals of the rheumatic diseases 2021 Oct;80;1330-1338 2021 Oct
Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
BMJ (Clinical research ed.) 2021 Jun 24;373;n1635 2021 Jun 24

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies